Angela Dispenzieri Selected Research

Immunoglobulin Light Chains (Immunoglobulin Light Chain)

1/2021	Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
1/2021	MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
1/2020	Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review.
1/2020	Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease.
1/2020	Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis.
1/2020	New developments in diagnosis, risk assessment and management in systemic amyloidosis.
1/2019	Heavy Chain Fibrillary Glomerulonephritis: A Case Report.
1/2019	Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis.
11/2018	Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis.
10/2018	Systemic immunoglobulin light chain amyloidosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela Dispenzieri Research Topics

Disease

166	Multiple Myeloma 12/2022 - 11/2002
135	Immunoglobulin Light-chain Amyloidosis 01/2022 - 03/2002
123	Amyloidosis 11/2022 - 01/2002
32	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 01/2002
27	POEMS Syndrome (Syndrome, POEMS) 12/2022 - 04/2003
23	Neoplasms (Cancer) 01/2022 - 01/2005
18	Monoclonal Gammopathy of Undetermined Significance 01/2022 - 07/2004
17	Plasmacytoma 01/2021 - 06/2004
16	Amyloid Plaque 09/2022 - 01/2002
16	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021 - 01/2002
15	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 01/2005
14	Disease Progression 04/2022 - 07/2004
13	Proteinuria 01/2022 - 01/2005
13	Cardiomyopathies (Cardiomyopathy) 11/2021 - 01/2002
12	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2021 - 07/2011
11	Castleman Disease (Castleman's Disease) 01/2022 - 07/2011
9	Transthyretin-Related Hereditary Amyloidosis 09/2022 - 07/2014
9	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 02/2005
9	Smoldering Multiple Myeloma 01/2021 - 07/2004
9	Anemia 11/2020 - 01/2003
8	Heart Failure 11/2021 - 04/2014
7	Lymphoma (Lymphomas) 01/2021 - 03/2011
6	Thrombocytosis (Thrombocythemia) 01/2022 - 05/2008
6	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 07/2004
6	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2018 - 01/2005
5	Polyneuropathies (Polyneuropathy) 01/2021 - 05/2015
5	Thrombocytopenia (Thrombopenia) 01/2020 - 04/2006
5	Hypercalcemia (Milk Alkali Syndrome) 01/2020 - 01/2003
5	Renal Insufficiency (Renal Failure) 12/2019 - 06/2010
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 03/2003
5	Familial Amyloidosis (Hereditary Amyloidosis) 01/2018 - 07/2014
4	Hypoalbuminemia 01/2022 - 01/2005
4	Pleural Effusion (Pleural Effusions) 01/2021 - 06/2010
4	Rare Diseases (Rare Disease) 01/2021 - 01/2008
4	Trisomy (Trisomies) 12/2020 - 09/2005
4	Cardiac Arrhythmias (Arrythmia) 12/2019 - 06/2010
4	Infections 10/2018 - 11/2002
4	Acute Kidney Injury (Acute Renal Failure) 06/2018 - 01/2005
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 09/2006
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 09/2005
3	Pulmonary Hypertension 01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

69	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
62	Amyloid (Amyloid Fibrils)IBA 09/2022 - 03/2003
43	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021 - 07/2005
39	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2002
36	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 11/2005
28	Lenalidomide (CC 5013)FDA Link 01/2022 - 10/2006
28	Immunoglobulin M (IgM)IBA 01/2021 - 01/2002
27	Bortezomib (Velcade)FDA Link 01/2022 - 07/2005
21	Prealbumin (Transthyretin)IBA 09/2022 - 12/2013
21	Thalidomide (Thalomid)FDA Link 01/2022 - 11/2002
16	Biomarkers (Surrogate Marker)IBA 05/2021 - 06/2010
15	Melphalan (Alkeran)FDA LinkGeneric 12/2021 - 01/2002
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2006
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2008
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 09/2004
9	Troponin T (Troponin T1)IBA 01/2021 - 05/2007
8	Immunoglobulin G (IgG)IBA 01/2022 - 06/2010
8	Congo RedIBA 01/2022 - 04/2013
8	Proteasome InhibitorsIBA 01/2022 - 05/2006
8	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 10/2010
8	CreatinineIBA 12/2020 - 01/2002
6	ixazomibIBA 01/2022 - 11/2016
6	Immunomodulating AgentsIBA 01/2022 - 10/2009
6	Pharmaceutical PreparationsIBA 01/2022 - 10/2010
6	pomalidomideIBA 03/2021 - 10/2009
6	Immunoglobulin A (IgA)IBA 01/2021 - 06/2010
6	Interleukin-6 (Interleukin 6)IBA 12/2020 - 02/2006
6	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2019 - 10/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
5	Biological ProductsIBA 10/2021 - 02/2006
5	Serum AlbuminIBA 01/2021 - 11/2005
5	TroponinIBA 10/2019 - 05/2003
5	Peptides (Polypeptides)IBA 02/2017 - 04/2014
4	patisiranIBA 01/2021 - 01/2019
4	AlbuminsIBA 12/2020 - 05/2007
4	VaccinesIBA 12/2020 - 12/2009
4	Radioisotopes (Radionuclides)IBA 01/2020 - 01/2002
4	daratumumabIBA 01/2020 - 11/2017
4	Rituximab (Mabthera)FDA Link 08/2018 - 09/2006
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 03/2007
4	Blood Proteins (Serum Proteins)IBA 10/2016 - 12/2011
4	Indicators and Reagents (Reagents)IBA 10/2015 - 02/2003
4	thiamine triphosphorate (TTP)IBA 06/2015 - 04/2003
4	Alkylating AgentsIBA 05/2012 - 03/2003
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
3	sodium-iodide symporter (sodium iodide symporter)IBA 01/2022 - 10/2017
3	AntibodiesIBA 01/2021 - 09/2006

Therapy/Procedure

146	Therapeutics 11/2022 - 01/2002
82	Stem Cell Transplantation 11/2022 - 11/2002
27	Drug Therapy (Chemotherapy) 01/2021 - 11/2002
16	Transplantation 10/2022 - 03/2003
13	Hematopoietic Stem Cell Transplantation 03/2021 - 03/2004
12	Kidney Transplantation 04/2022 - 07/2005
11	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2015 - 01/2002
9	Autologous Transplantation 01/2017 - 12/2009
8	Cell Transplantation 12/2022 - 08/2011
4	Lasers (Laser) 10/2019 - 12/2010
4	Radiotherapy 08/2017 - 07/2005
3	Hematopoietic Stem Cell Mobilization 01/2021 - 11/2005